Listed

Pulse Biosciences, Inc.

PLSENasdaqCIK 1625101HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$434.0k, Q2 FY2026
Operating income−$25.3m, Q2 FY2026
Net income−$24.7m, Q2 FY2026
Pulse Biosciences, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001437749-25-009932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure0.1Revenue, Q3 FY2025, three months to 2025-09-30$86.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure0.3Revenue, Q4 FY2025, three months to 2025-12-31$264.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure0.4Revenue, Q1 FY2026, three months to 2026-03-31$401.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure0.4Revenue, Q2 FY2026, three months to 2026-06-30$434.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Cost of revenue$m0.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2023-11-13, accession 0001437749-23-031686.Report this figure0.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2024-03-28, accession 0001437749-24-009815. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure0.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure0.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$279.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure0.3Cost of revenue, Q4 FY2025, three months to 2025-12-31$260.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure0.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$370.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure0.3Cost of revenue, Q2 FY2026, three months to 2026-06-30$273.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Research and development$m7.5Research and development, Q3 FY2023, three months to 2023-09-30$7.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure7.8Research and development, Q4 FY2023, three months to 2023-12-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001437749-25-009932. Derived: 12-month figure less the 9-month figure.Report this figure6.7Research and development, Q1 FY2024, three months to 2024-03-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure7.2Research and development, Q2 FY2024, three months to 2024-06-30$7.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure7.7Research and development, Q3 FY2024, three months to 2024-09-30$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure10.7Research and development, Q4 FY2024, three months to 2024-12-31$10.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure10.3Research and development, Q1 FY2025, three months to 2025-03-31$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure12.1Research and development, Q2 FY2025, three months to 2025-06-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure11.4Research and development, Q3 FY2025, three months to 2025-09-30$11.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure10.9Research and development, Q4 FY2025, three months to 2025-12-31$10.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure12.6Research and development, Q1 FY2026, three months to 2026-03-31$12.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure17.0Research and development, Q2 FY2026, three months to 2026-06-30$17.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reported6.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$6.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure9.6Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$9.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure7.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$7.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure8.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$8.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure8.8Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$8.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure7.3Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$7.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure6.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$6.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure8.5Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$8.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Operating income$m(11.3)Operating income, Q3 FY2023, three months to 2023-09-30−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure(12.5)Operating income, Q4 FY2023, three months to 2023-12-31−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001437749-25-009932. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Operating income, Q1 FY2024, three months to 2024-03-31−$10.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure(11.7)Operating income, Q2 FY2024, three months to 2024-06-30−$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure(13.7)Operating income, Q3 FY2024, three months to 2024-09-30−$13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure(20.3)Operating income, Q4 FY2024, three months to 2024-12-31−$20.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Operating income, Q1 FY2025, three months to 2025-03-31−$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure(20.3)Operating income, Q2 FY2025, three months to 2025-06-30−$20.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure(20.4)Operating income, Q3 FY2025, three months to 2025-09-30−$20.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure(18.3)Operating income, Q4 FY2025, three months to 2025-12-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure(19.2)Operating income, Q1 FY2026, three months to 2026-03-31−$19.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure(25.3)Operating income, Q2 FY2026, three months to 2026-06-30−$25.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001437749-25-009932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figurenot reportednot reportednot reportednot reported
Net income$m(10.6)Net income, Q3 FY2023, three months to 2023-09-30−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure(11.9)Net income, Q4 FY2023, three months to 2023-12-31−$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001437749-25-009932. Derived: 12-month figure less the 9-month figure.Report this figure(10.1)Net income, Q1 FY2024, three months to 2024-03-31−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure(11.4)Net income, Q2 FY2024, three months to 2024-06-30−$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure(12.7)Net income, Q3 FY2024, three months to 2024-09-30−$12.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure(19.4)Net income, Q4 FY2024, three months to 2024-12-31−$19.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure(16.8)Net income, Q1 FY2025, three months to 2025-03-31−$16.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure(19.2)Net income, Q2 FY2025, three months to 2025-06-30−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure(19.4)Net income, Q3 FY2025, three months to 2025-09-30−$19.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure(17.4)Net income, Q4 FY2025, three months to 2025-12-31−$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure(18.6)Net income, Q1 FY2026, three months to 2026-03-31−$18.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure(24.7)Net income, Q2 FY2026, three months to 2026-06-30−$24.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(0.19)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figurenot reported(0.18)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure(0.20)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure(0.21)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figurenot reported(0.25)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure(0.28)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure(0.29)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figurenot reported(0.27)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure(0.36)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure

Balance sheet

Cash and equivalents$101.6m, Q2 FY2026
Shareholders' equity$99.5m, Q2 FY2026
Pulse Biosciences, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m50.4Cash and equivalents, Q3 FY2023, at 2023-09-30$50.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001437749-23-031686.Report this figure44.4Cash and equivalents, FY2023, at 2023-12-31$44.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001437749-25-009932.Report this figure34.9Cash and equivalents, Q1 FY2024, at 2024-03-31$34.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001437749-24-015092.Report this figure26.2Cash and equivalents, Q2 FY2024, at 2024-06-30$26.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-19, accession 0001437749-24-027213.Report this figure79.0Cash and equivalents, Q3 FY2024, at 2024-09-30$79.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure118Cash and equivalents, FY2024, at 2024-12-31$118.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-19, accession 0001437749-26-004724.Report this figure119Cash and equivalents, Q1 FY2025, at 2025-03-31$119.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure106Cash and equivalents, Q2 FY2025, at 2025-06-30$106.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure95.2Cash and equivalents, Q3 FY2025, at 2025-09-30$95.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure80.7Cash and equivalents, FY2025, at 2025-12-31$80.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure68.3Cash and equivalents, Q1 FY2026, at 2026-03-31$68.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure102Cash and equivalents, Q2 FY2026, at 2026-06-30$101.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Current assets$m51.6Current assets, Q3 FY2023, at 2023-09-30$51.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001437749-23-031686.Report this figure45.3Current assets, FY2023, at 2023-12-31$45.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001437749-25-009932.Report this figure35.8Current assets, Q1 FY2024, at 2024-03-31$35.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001437749-24-015092.Report this figure27.2Current assets, Q2 FY2024, at 2024-06-30$27.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-19, accession 0001437749-24-027213.Report this figure80.4Current assets, Q3 FY2024, at 2024-09-30$80.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure119Current assets, FY2024, at 2024-12-31$119.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-19, accession 0001437749-26-004724.Report this figure121Current assets, Q1 FY2025, at 2025-03-31$120.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure108Current assets, Q2 FY2025, at 2025-06-30$108.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure97.2Current assets, Q3 FY2025, at 2025-09-30$97.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure83.4Current assets, FY2025, at 2025-12-31$83.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure71.1Current assets, Q1 FY2026, at 2026-03-31$71.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure106Current assets, Q2 FY2026, at 2026-06-30$105.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Total assets$m65.9Total assets, Q3 FY2023, at 2023-09-30$65.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001437749-23-031686.Report this figure59.2Total assets, FY2023, at 2023-12-31$59.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001437749-25-009932.Report this figure49.2Total assets, Q1 FY2024, at 2024-03-31$49.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001437749-24-015092.Report this figure40.4Total assets, Q2 FY2024, at 2024-06-30$40.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-19, accession 0001437749-24-027213.Report this figure93.0Total assets, Q3 FY2024, at 2024-09-30$93.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure132Total assets, FY2024, at 2024-12-31$132.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-19, accession 0001437749-26-004724.Report this figure133Total assets, Q1 FY2025, at 2025-03-31$133.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure120Total assets, Q2 FY2025, at 2025-06-30$120.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure109Total assets, Q3 FY2025, at 2025-09-30$108.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure94.5Total assets, FY2025, at 2025-12-31$94.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure81.6Total assets, Q1 FY2026, at 2026-03-31$81.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure116Total assets, Q2 FY2026, at 2026-06-30$115.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Current liabilities$m5.4Current liabilities, Q3 FY2023, at 2023-09-30$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001437749-23-031686.Report this figure6.7Current liabilities, FY2023, at 2023-12-31$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001437749-25-009932.Report this figure5.1Current liabilities, Q1 FY2024, at 2024-03-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001437749-24-015092.Report this figure6.0Current liabilities, Q2 FY2024, at 2024-06-30$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-19, accession 0001437749-24-027213.Report this figure6.7Current liabilities, Q3 FY2024, at 2024-09-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure10.1Current liabilities, FY2024, at 2024-12-31$10.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-19, accession 0001437749-26-004724.Report this figure7.8Current liabilities, Q1 FY2025, at 2025-03-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure9.0Current liabilities, Q2 FY2025, at 2025-06-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure9.7Current liabilities, Q3 FY2025, at 2025-09-30$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure7.9Current liabilities, FY2025, at 2025-12-31$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure9.8Current liabilities, Q1 FY2026, at 2026-03-31$9.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure11.0Current liabilities, Q2 FY2026, at 2026-06-30$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Total liabilities$m13.8Total liabilities, Q3 FY2023, at 2023-09-30$13.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001437749-23-031686.Report this figure14.8Total liabilities, FY2023, at 2023-12-31$14.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001437749-25-009932.Report this figure12.9Total liabilities, Q1 FY2024, at 2024-03-31$12.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001437749-24-015092.Report this figure13.5Total liabilities, Q2 FY2024, at 2024-06-30$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-19, accession 0001437749-24-027213.Report this figure13.9Total liabilities, Q3 FY2024, at 2024-09-30$13.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure17.6Total liabilities, FY2024, at 2024-12-31$17.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-19, accession 0001437749-26-004724.Report this figure14.9Total liabilities, Q1 FY2025, at 2025-03-31$14.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure15.8Total liabilities, Q2 FY2025, at 2025-06-30$15.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure16.1Total liabilities, Q3 FY2025, at 2025-09-30$16.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure13.9Total liabilities, FY2025, at 2025-12-31$13.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure15.3Total liabilities, Q1 FY2026, at 2026-03-31$15.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure16.1Total liabilities, Q2 FY2026, at 2026-06-30$16.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure
Shareholders' equity$m52.1Shareholders' equity, Q3 FY2023, at 2023-09-30$52.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-30, accession 0001437749-24-032614.Report this figure44.4Shareholders' equity, FY2023, at 2023-12-31$44.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-19, accession 0001437749-26-004724.Report this figure36.3Shareholders' equity, Q1 FY2024, at 2024-03-31$36.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001437749-25-026209.Report this figure27.0Shareholders' equity, Q2 FY2024, at 2024-06-30$27.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure79.1Shareholders' equity, Q3 FY2024, at 2024-09-30$79.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure115Shareholders' equity, FY2024, at 2024-12-31$114.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure118Shareholders' equity, Q1 FY2025, at 2025-03-31$118.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure104Shareholders' equity, Q2 FY2025, at 2025-06-30$104.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure92.7Shareholders' equity, Q3 FY2025, at 2025-09-30$92.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033354.Report this figure80.7Shareholders' equity, FY2025, at 2025-12-31$80.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure66.3Shareholders' equity, Q1 FY2026, at 2026-03-31$66.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure99.5Shareholders' equity, Q2 FY2026, at 2026-06-30$99.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure

Cash flow

Operating cash flow−$18.7m, Q2 FY2026
Capital expenditure$90.0k, Q2 FY2026
Pulse Biosciences, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(10.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-30, accession 0001437749-24-032614. Derived: 9-month figure less the 6-month figure.Report this figure(6.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001437749-25-009932. Derived: 12-month figure less the 9-month figure.Report this figure(9.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure(8.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001437749-25-026209. Derived: 6-month figure less the 3-month figure.Report this figure(9.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001437749-25-033354. Derived: 9-month figure less the 6-month figure.Report this figure(9.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure(13.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure(12.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001437749-26-026288. Derived: 6-month figure less the 3-month figure.Report this figure(13.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001437749-25-033354. Derived: 9-month figure less the 6-month figure.Report this figure(14.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure(14.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure(18.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$18.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001437749-26-026288. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-30, accession 0001437749-24-032614. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001437749-25-009932. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001437749-25-015565.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001437749-25-026209. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$38.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001437749-25-033354. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$53.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$45.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$103.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001437749-26-026288. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001437749-25-033354. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$105.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001437749-26-004724. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$33.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-016897.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001437749-26-026288. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)37.16m, Q3 FY2022
Pulse Biosciences, Inc., shares, quarterly
Line itemUnitQ2 FY20212021-06-30Q3 FY20212021-09-30Q2 FY20222022-06-30Q3 FY20222022-09-30
Diluted shares (weighted)m shares26.5Diluted shares (weighted), Q2 FY2021, three months to 2021-06-3026,477,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-08-10, accession 0001625101-22-000061.Report this figure29.6Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3029,612,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-10, accession 0001625101-22-000067.Report this figure31.5Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3031,492,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-08-10, accession 0001625101-22-000061.Report this figure37.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3037,158,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-10, accession 0001625101-22-000067.Report this figure

Shares outstanding: 71.32mShares outstanding, period not labelled, at 2026-07-3171,322,607 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001437749-26-026288.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.